LYN-00101

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLYN-00101
Drug Alias NameLY-00101LYN-00101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factorVascular endothelial growth factor receptor
Therapy Area/IndicationsUterine Cervical NeoplasmsOvarian NeoplasmsStomach Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLynkcell Inc
China Registration ClassN/A

Develop Information

Active CompaniesLynkcell Inc
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsOvarian NeoplasmsStomach Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A